oral drugs, with the former used as induction agents followed by oral anti-obesity medicines in the maintenance phase
One of the downsides of rapid weight loss is losing muscle mass
Instead, focus on developing better eating habits
While some people can obtain adequate B12 from a balanced diet, others may need injections, especially if they have absorption issues or dietary restrictions
The company will start regulatory filings for these markets in early 2026 and expects gains to start coming in from calendar year 2027
These agents include: Liraglutide (Victoza, Saxenda) once-daily injection Semaglutide (Ozempic, Wegovy) once-weekly Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist From Glycaemic Control to Weight Regulation GLP-1RAs were initially licensed to lower HbA1c in people with Type 2 diabetes, offering an alternative to sulfonylureas and insulin